…To examine associations between changes in depression, stress, and self-reported prenatal cannabis use (PCU), to examine motives for PCU, and to examine whether trajectories of depression and stress vary across…
…by THC-dominant (23%), a THC:CBD balanced ratio (7%), and minor cannabinoid products such as CBG or CBN at 5%. Most individuals who reported using a THC-dominant product were also using…
…improvement in symptoms of anxiety and depression with both the onset of cannabis use and with extended use. Limiting stress to limit depression Depression itself is considered a…
…after adjustment for depression. Six studies investigated a potential moderating role of depression, with four reporting significant but conflicting results. No article investigated the mediating role of depression. Discussion There…
…The studies assessing cannabis use and depression at different points from adolescence to young adulthood and reporting the corresponding OR were included. In the studies selected, depression was diagnosed according…
…dose-dependent: 10–15 mg of oral THC and at least 3 puffs of vaporized cannabis yielded the most robust reductions in anxiety and depression. Conclusions Initiation of THC-dominant medicinal cannabis was…
…through their interaction with cannabinoid receptors, Lowe explained. “Major cannabinoids that have been identified include delta-9-tetrahydrocannabinol (delta-9-THC; the main psychoactive constituent of cannabis), cannabidiol (CBD), tetrahydrocannabivarin (THCV), cannabinol (CBN), cannabigerol…
Please use this link to access this publication: https://www.cambridge.org/core/journals/psychological-medicine/article/abs/association-between-cannabis-use-and-depression-a-systematic-review-and-metaanalysis-of-longitudinal-studies/B144B7AE5A3D973289DBDD99ADE21E58 Abstract BackgroundLongitudinal studies reporting the association between cannabis use and developing depression provide mixed results. The objective of this study was…
…little is known about whether comorbid depression alters the effectiveness of CBMPs. Aims: To document the prevalence of depression among individuals seeking CBMPs to treat PTSD and to examine whether…
…having anxiety and/or depression without a specific endorsement, as well as specific endorsements, including: major depressive disorder, postpartum depression, dysthymia, premenstrual dysphoric disorder, seasonal affective disorder, generalized anxiety disorder, panic…
